SynthesisClinical rheumatology2021

Janus kinase inhibitors and major COVID-19 outcomes: time to forget the two faces of Janus! A meta-analysis of randomized controlled trials.

Dimitrios Patoulias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.